1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Polymerase Chain Reaction PCR 1.2.3 Molecular Hybridization 1.2.4 Biochip 1.2.5 Others 1.3 Market by Application 1.3.1 Global Infectious Diseases Molecular Diagnostics Kit Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospital 1.3.3 Third-party Testing Agency 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Infectious Diseases Molecular Diagnostics Kit Market Perspective (2018-2029) 2.2 Infectious Diseases Molecular Diagnostics Kit Growth Trends by Region 2.2.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Infectious Diseases Molecular Diagnostics Kit Historic Market Size by Region (2018-2023) 2.2.3 Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Region (2024-2029) 2.3 Infectious Diseases Molecular Diagnostics Kit Market Dynamics 2.3.1 Infectious Diseases Molecular Diagnostics Kit Industry Trends 2.3.2 Infectious Diseases Molecular Diagnostics Kit Market Drivers 2.3.3 Infectious Diseases Molecular Diagnostics Kit Market Challenges 2.3.4 Infectious Diseases Molecular Diagnostics Kit Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Infectious Diseases Molecular Diagnostics Kit Players by Revenue 3.1.1 Global Top Infectious Diseases Molecular Diagnostics Kit Players by Revenue (2018-2023) 3.1.2 Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Players (2018-2023) 3.2 Global Infectious Diseases Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Infectious Diseases Molecular Diagnostics Kit Revenue 3.4 Global Infectious Diseases Molecular Diagnostics Kit Market Concentration Ratio 3.4.1 Global Infectious Diseases Molecular Diagnostics Kit Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Molecular Diagnostics Kit Revenue in 2022 3.5 Infectious Diseases Molecular Diagnostics Kit Key Players Head office and Area Served 3.6 Key Players Infectious Diseases Molecular Diagnostics Kit Product Solution and Service 3.7 Date of Enter into Infectious Diseases Molecular Diagnostics Kit Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Infectious Diseases Molecular Diagnostics Kit Breakdown Data by Type 4.1 Global Infectious Diseases Molecular Diagnostics Kit Historic Market Size by Type (2018-2023) 4.2 Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Type (2024-2029) 5 Infectious Diseases Molecular Diagnostics Kit Breakdown Data by Application 5.1 Global Infectious Diseases Molecular Diagnostics Kit Historic Market Size by Application (2018-2023) 5.2 Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Infectious Diseases Molecular Diagnostics Kit Market Size (2018-2029) 6.2 North America Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2018-2023) 6.4 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Infectious Diseases Molecular Diagnostics Kit Market Size (2018-2029) 7.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2018-2023) 7.4 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size (2018-2029) 8.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2018-2023) 8.4 Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Infectious Diseases Molecular Diagnostics Kit Market Size (2018-2029) 9.2 Latin America Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2018-2023) 9.4 Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size (2018-2029) 10.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2018-2023) 10.4 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Detail 11.1.2 Roche Business Overview 11.1.3 Roche Infectious Diseases Molecular Diagnostics Kit Introduction 11.1.4 Roche Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.1.5 Roche Recent Development 11.2 Qiagen 11.2.1 Qiagen Company Detail 11.2.2 Qiagen Business Overview 11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Kit Introduction 11.2.4 Qiagen Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.2.5 Qiagen Recent Development 11.3 Illumina 11.3.1 Illumina Company Detail 11.3.2 Illumina Business Overview 11.3.3 Illumina Infectious Diseases Molecular Diagnostics Kit Introduction 11.3.4 Illumina Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.3.5 Illumina Recent Development 11.4 Abbott 11.4.1 Abbott Company Detail 11.4.2 Abbott Business Overview 11.4.3 Abbott Infectious Diseases Molecular Diagnostics Kit Introduction 11.4.4 Abbott Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.4.5 Abbott Recent Development 11.5 Hologic 11.5.1 Hologic Company Detail 11.5.2 Hologic Business Overview 11.5.3 Hologic Infectious Diseases Molecular Diagnostics Kit Introduction 11.5.4 Hologic Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.5.5 Hologic Recent Development 11.6 BioMerieux 11.6.1 BioMerieux Company Detail 11.6.2 BioMerieux Business Overview 11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Kit Introduction 11.6.4 BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.6.5 BioMerieux Recent Development 11.7 Danaher (Cepheid) 11.7.1 Danaher (Cepheid) Company Detail 11.7.2 Danaher (Cepheid) Business Overview 11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Introduction 11.7.4 Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.7.5 Danaher (Cepheid) Recent Development 11.8 Myriad Genetics 11.8.1 Myriad Genetics Company Detail 11.8.2 Myriad Genetics Business Overview 11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Introduction 11.8.4 Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.8.5 Myriad Genetics Recent Development 11.9 DAAN Gene 11.9.1 DAAN Gene Company Detail 11.9.2 DAAN Gene Business Overview 11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Introduction 11.9.4 DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.9.5 DAAN Gene Recent Development 11.10 Agilent 11.10.1 Agilent Company Detail 11.10.2 Agilent Business Overview 11.10.3 Agilent Infectious Diseases Molecular Diagnostics Kit Introduction 11.10.4 Agilent Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.10.5 Agilent Recent Development 11.11 Genomic Health 11.11.1 Genomic Health Company Detail 11.11.2 Genomic Health Business Overview 11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Kit Introduction 11.11.4 Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.11.5 Genomic Health Recent Development 11.12 BD 11.12.1 BD Company Detail 11.12.2 BD Business Overview 11.12.3 BD Infectious Diseases Molecular Diagnostics Kit Introduction 11.12.4 BD Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.12.5 BD Recent Development 11.13 Foundation Medicine 11.13.1 Foundation Medicine Company Detail 11.13.2 Foundation Medicine Business Overview 11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Introduction 11.13.4 Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) 11.13.5 Foundation Medicine Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Polymerase Chain Reaction PCR Table 3. Key Players of Molecular Hybridization Table 4. Key Players of Biochip Table 5. Key Players of Others Table 6. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2018-2023) & (US$ Million) Table 9. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Region (2018-2023) Table 10. Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Region (2024-2029) Table 12. Infectious Diseases Molecular Diagnostics Kit Market Trends Table 13. Infectious Diseases Molecular Diagnostics Kit Market Drivers Table 14. Infectious Diseases Molecular Diagnostics Kit Market Challenges Table 15. Infectious Diseases Molecular Diagnostics Kit Market Restraints Table 16. Global Infectious Diseases Molecular Diagnostics Kit Revenue by Players (2018-2023) & (US$ Million) Table 17. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Players (2018-2023) Table 18. Global Top Infectious Diseases Molecular Diagnostics Kit Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics Kit as of 2022) Table 19. Ranking of Global Top Infectious Diseases Molecular Diagnostics Kit Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by Infectious Diseases Molecular Diagnostics Kit Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Infectious Diseases Molecular Diagnostics Kit Product Solution and Service Table 23. Date of Enter into Infectious Diseases Molecular Diagnostics Kit Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2018-2023) & (US$ Million) Table 26. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Type (2018-2023) Table 27. Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Type (2024-2029) Table 29. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2018-2023) & (US$ Million) Table 30. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Application (2018-2023) Table 31. Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Application (2024-2029) Table 33. North America Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2018-2023) & (US$ Million) Table 35. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2024-2029) & (US$ Million) Table 48. Roche Company Detail Table 49. Roche Business Overview Table 50. Roche Infectious Diseases Molecular Diagnostics Kit Product Table 51. Roche Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 52. Roche Recent Development Table 53. Qiagen Company Detail Table 54. Qiagen Business Overview Table 55. Qiagen Infectious Diseases Molecular Diagnostics Kit Product Table 56. Qiagen Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 57. Qiagen Recent Development Table 58. Illumina Company Detail Table 59. Illumina Business Overview Table 60. Illumina Infectious Diseases Molecular Diagnostics Kit Product Table 61. Illumina Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 62. Illumina Recent Development Table 63. Abbott Company Detail Table 64. Abbott Business Overview Table 65. Abbott Infectious Diseases Molecular Diagnostics Kit Product Table 66. Abbott Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 67. Abbott Recent Development Table 68. Hologic Company Detail Table 69. Hologic Business Overview Table 70. Hologic Infectious Diseases Molecular Diagnostics Kit Product Table 71. Hologic Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 72. Hologic Recent Development Table 73. BioMerieux Company Detail Table 74. BioMerieux Business Overview Table 75. BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Table 76. BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 77. BioMerieux Recent Development Table 78. Danaher (Cepheid) Company Detail Table 79. Danaher (Cepheid) Business Overview Table 80. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Table 81. Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 82. Danaher (Cepheid) Recent Development Table 83. Myriad Genetics Company Detail Table 84. Myriad Genetics Business Overview Table 85. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Table 86. Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 87. Myriad Genetics Recent Development Table 88. DAAN Gene Company Detail Table 89. DAAN Gene Business Overview Table 90. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Table 91. DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 92. DAAN Gene Recent Development Table 93. Agilent Company Detail Table 94. Agilent Business Overview Table 95. Agilent Infectious Diseases Molecular Diagnostics Kit Product Table 96. Agilent Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 97. Agilent Recent Development Table 98. Genomic Health Company Detail Table 99. Genomic Health Business Overview Table 100. Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Table 101. Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 102. Genomic Health Recent Development Table 103. BD Company Detail Table 104. BD Business Overview Table 105. BD Infectious Diseases Molecular Diagnostics Kit Product Table 106. BD Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 107. BD Recent Development Table 108. Foundation Medicine Company Detail Table 109. Foundation Medicine Business Overview Table 110. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Table 111. Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) & (US$ Million) Table 112. Foundation Medicine Recent Development Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Global Infectious Diseases Molecular Diagnostics Kit Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Type: 2022 VS 2029 Figure 3. Polymerase Chain Reaction PCR Features Figure 4. Molecular Hybridization Features Figure 5. Biochip Features Figure 6. Others Features Figure 7. Global Infectious Diseases Molecular Diagnostics Kit Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application: 2022 VS 2029 Figure 9. Hospital Case Studies Figure 10. Third-party Testing Agency Case Studies Figure 11. Others Case Studies Figure 12. Infectious Diseases Molecular Diagnostics Kit Report Years Considered Figure 13. Global Infectious Diseases Molecular Diagnostics Kit Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Infectious Diseases Molecular Diagnostics Kit Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Region: 2022 VS 2029 Figure 16. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Players in 2022 Figure 17. Global Top Infectious Diseases Molecular Diagnostics Kit Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics Kit as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Infectious Diseases Molecular Diagnostics Kit Revenue in 2022 Figure 19. North America Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2018-2029) Figure 21. United States Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2018-2029) Figure 25. Germany Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Infectious Diseases Molecular Diagnostics Kit Market Share by Region (2018-2029) Figure 33. China Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2018-2029) Figure 41. Mexico Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2018-2029) Figure 45. Turkey Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Roche Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 48. Qiagen Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 49. Illumina Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 50. Abbott Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 51. Hologic Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 52. BioMerieux Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 53. Danaher (Cepheid) Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 54. Myriad Genetics Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 55. DAAN Gene Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 56. Agilent Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 57. Genomic Health Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 58. BD Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 59. Foundation Medicine Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2018-2023) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Roche Qiagen Illumina Abbott Hologic BioMerieux Danaher (Cepheid) Myriad Genetics DAAN Gene Agilent Genomic Health BD Foundation Medicine